News

HealingMaps Unveils AI-Powered Chatbot in Collaboration with Vellum.AI

Innovative AI Tool Connects Users to Psychedelic-Assisted Therapy InformationMiami, Florida--(Newsfile Corp. - April 24, 2024) - HealingMaps, a premier directory…

2 years ago

Psirenity Health and Pickleball Ontario Sign a Three-Year Partnership

Psirenity Health will be the Official "Wellness Partner" of Pickleball OntarioOakville, Ontario--(Newsfile Corp. - April 24, 2024) - Psirenity Health…

2 years ago

Moderna and OpenAI Collaborate To Advance mRNA Medicine

Generative AI will help advance Moderna's broad and diverse portfolio to maximize the Company's impact on patientsModerna embeds OpenAI's generative…

2 years ago

Dr. Amir Bajoghli Receives Top Doctor Award 2024 in Dermatology by Northern Virginia Magazine

MCLEAN, VA / ACCESSWIRE / April 24, 2024 / MCLEAN, VA / ACCESSWIRE / April 24, 2022 / Dr. Bajoghli…

2 years ago

Vytalize Health Announces Key Leadership Additions to Support Continued Excellence in Value-Based Care

New CIO, CFO & SVP of Clinical Performance join one of the nation's leading provider enablement platforms with a focus…

2 years ago

Clearstep Partners with Ochsner Health to Tackle Healthcare Access and Capacity Challenges

Leveraging advanced AI technology, the collaboration aims to improve care routing for more than 1.5 million patients CHICAGO, IL /…

2 years ago

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

Organizational redesign and rightsizing initiated across company to streamline structures, increase efficiency and reduce operating costsTogether with GSK, ended Pandemic…

2 years ago

CureVac Appoints Thaminda Ramanayake as New Chief Business Officer

Mr. Ramanayake brings more than fifteen years of experience in biopharma company development and deal-makingStrong track record of successful clinical…

2 years ago

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK

Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza (H5N1)…

2 years ago

Senzime publishes annual and sustainability report for 2023

UPPSALA, SE / ACCESSWIRE / April 24, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ) announces today that the company's annual…

2 years ago